Pimozide for tics in Tourette's syndrome.

Author: MarrasConnie, PringsheimTamara

Paper Details 
Original Abstract of the Article :
Neuroleptic drugs with potent D-2 receptor blocking properties have been the traditional treatment for tics caused by Tourette Syndrome. Pimozide is the most studied of these. Use of these medications is declining because of concerns about side effects, and new atypical neuroleptics are now availabl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212051/

データ提供:米国国立医学図書館(NLM)

Pimozide for Tics: A Balancing Act Between Benefits and Risks

The world of neurology is a vast desert, and finding the right treatment for Tourette's syndrome is like searching for a shimmering oasis. This research delves into the traditional treatment for tics: neuroleptic drugs. They work by blocking D-2 receptors, but they can be like a mirage, offering a temporary solution with potential side effects. Pimozide, a neuroleptic, has been studied extensively, but its true benefits and risks compared to newer atypical neuroleptics are still under investigation.

The Need for New Approaches

The use of traditional neuroleptics is declining, highlighting the need for alternative treatments with better safety profiles. This research suggests that we need to continue exploring the vast landscape of neurology to find more effective and safer options for patients with Tourette's syndrome.

Navigating the Desert of Treatment Options

This research reminds us that navigating the desert of treatment options for Tourette's syndrome is a delicate balancing act between benefits and risks. While traditional neuroleptics like pimozide offer a temporary oasis, they come with a risk of side effects. The search for better and safer treatments continues.

Dr.Camel's Conclusion

The quest for effective treatments for Tourette's syndrome continues, and the research on pimozide adds another layer to our understanding of the potential benefits and risks of neuroleptics. It's essential to work together, like a caravan traversing the desert, to find the most effective and safest options for patients.

Date :
  1. Date Completed 2009-06-23
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

19370666

DOI: Digital Object Identifier

PMC7212051

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.